Our in silico results together with the results from in vivo manipulation of IL-17 in two syngeneic melanoma ICI models suggest that the IL-17-associated presence of neutrophils could support the anti-tumor response in patients with melanoma to dual ICI. This evidence concerns the gene IL17A and neoplasm.